Adventist Hinsdale Hospital and Adventist La Grange Memorial Hospital are pleased to welcome three new members to its radiation oncology team: Drs. Brian Moran, Katherine Baker and Jeffrey Feinstein.
Dr. Moran is the medical director of Chicago Prostate Cancer Center, which he helped found in 1997. He has been performing prostate seed implants – a minimally invasive procedure that kills cancer cells with radiation while preserving healthy tissue – since 1994. Moran was the previous medical director of Alexian Brothers Medical Center, and also was an attending physician at Lutheran General Hospital. He began the High Dose Rate (HDR) program at both sites and has expertise in prostate, head and neck, skin and gynecological cancers.
This Hinsdale resident is a graduate of Loyola Stritch School of Medicine, where he also performed his residency and acted as chief resident. He is certified by the American Board of Radiology and is a member of numerous medical societies including the American Society of Therapeutic Radiology and Oncology and the American Brachytherapy Society. His emphasis has been on quality of life issues and long-term outcomes for cancer patients. Dr. Moran is a frequent speaker at professional meetings, and has authored numerous publications in medical journals and textbooks.
“I’m excited to join a hospital that takes such great pride in delivering university-level health care to the community,” Dr. Moran said.
Dr. Baker is a 1994 graduate of the University Of Wisconsin Medical School. She performed her residency and acted as chief resident at Rush University in Chicago. Following residency, she joined the staff at Rush Presbyterian St. Luke’s as an associate professor. Dr. Baker also practiced at Rush North Shore Hospital and River Forest Cancer Center.
This Chicago resident has expertise in breast, lung and gastrointestinal cancers. She has experience in the use of intensity modulated radiation therapy (IMRT), stereotactic radiosurgery, brachytherapy, total body irradiation, and radioactive iodine administration. She is certified by the American Board of Radiology and is a member of the American Society of Therapeutic Radiology and Oncology. Dr. Baker has written numerous papers and given presentations at national meetings.
“Adventist Midwest Health’s commitment to meeting the comprehensive needs of cancer patients and their families impressed me,” Dr. Baker said.
Dr. Feinstein is a 1971 graduate of New York University School of Medicine. He performed his residency in radiation oncology at New York University-Bellevue Medical Center, and has rendered radiation oncology services at Adventist Hinsdale Hospital since 1977. He was also on staff at University of Chicago Medical Center and Medical Director of Radiation Oncology at University of Illinois at Chicago Medical Center. He has expertise in head, neck, gynecological, brain, lung, and prostate cancers. He is experienced in the use of IMRT, stereotactic radiosurgery, brachytherapy, radionuclide therapies, and superficial hyperthermia.
This Hinsdale resident is certified by the American Board of Radiology, and member of multiple societies including the American Society of Therapeutic Radiology and Oncology. Dr. Feinstein has authored a number of articles and presentations on Radiation Oncology, and is the radiation oncology editor of Hematology Oncology Magazine.
“Joining this team of well-known and highly regarded physicians along with our excellent staff of oncology nurses, certified medical dosimetrists, and certified radiation therapists is a remarkable opportunity,” Feinstein said.
Michael Quaranta, director of radiology and oncology at Adventist Hinsdale Hospital, called Moran, Baker and Feinstein “distinguished physicians” who will complement the hospital’s existing radiology and oncology team.
“Our radiation oncologists use the latest treatments and technologies to aid in the treatment process,” Quaranta said. “Drs. Moran, Baker and Feinstein are trained in image-guided radiation therapy (IGRT), one of the most cutting-edge innovations in fighting cancer.”
IGRT combines imaging and treatment capabilities on a single machine. Because tumors can move, IGRT allows doctors to see and track the tumor at the time of treatment and to make very fine adjustments to a patient’s position so as to greatly increase the precision and accuracy of their radiation therapy treatment. Knowing exactly where the tumor is allows clinicians to irradiate only the tumor, sparing the surrounding normal tissue. This accuracy results in higher radiation doses to the tumor and thereby increased likelihood of controlling or eliminating the cancer.
With IGRT, the full radiation dose can be delivered in one session or over a course of several sessions. IGRT is well suited to treating tumors virtually anywhere in the body including those areas that are affected by respiratory motion.